Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Levetiracetam for Treatment-Refractory Posttraumatic Stress Disorder. PDF $40.00
$40.00
× Placeholder Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF $40.00
$40.00
× Placeholder Emerging Therapies for Attention-Deficit/Hyperactivity Disorder PDF $0.00
$0.00
× Placeholder Microstructural Differences in the Corpus Callosum in Patients With Bipolar Disorder and Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Deipnophobia: A Case of Social Anxiety Masquerading as Eating Issues PDF $40.00
$40.00
× Placeholder Valproate and Neuroleptic Malignant Syndrome in an Elderly Patient With Schizoaffective Disorder PDF $40.00
$40.00
× Placeholder A Randomized Controlled Trial of Olanzapine Versus Haloperidol in the Treatment of Primary Negative Symptoms and Neurocognitive Deficits in Schizophrenia PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $240.00
Total $240.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe